255 related articles for article (PubMed ID: 10924042)
1. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo.
Nishikawa Y; Stepp DW; Chilian WM
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H459-65. PubMed ID: 10924042
[TBL] [Abstract][Full Text] [Related]
2. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation.
Nishikawa Y; Stepp DW; Chilian WM
Am J Physiol; 1999 Sep; 277(3):H1252-9. PubMed ID: 10484447
[TBL] [Abstract][Full Text] [Related]
3. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels.
Miura H; Liu Y; Gutterman DD
Circulation; 1999 Jun; 99(24):3132-8. PubMed ID: 10377076
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-dependent regulation of coronary tone in the neonatal pig.
McGowan FX; Davis PJ; del Nido PJ; Sobek M; Allen JW; Downing SE
Anesth Analg; 1994 Dec; 79(6):1094-101. PubMed ID: 7978431
[TBL] [Abstract][Full Text] [Related]
5. Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilatation in dogs.
Komaru T; Lamping KG; Eastham CL; Harrison DG; Marcus ML; Dellsperger KC
Am J Physiol; 1991 Dec; 261(6 Pt 2):H2001-7. PubMed ID: 1750548
[TBL] [Abstract][Full Text] [Related]
6. Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels.
Terata K; Miura H; Liu Y; Loberiza F; Gutterman DD
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2620-6. PubMed ID: 11087213
[TBL] [Abstract][Full Text] [Related]
7. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
8. In vivo role of heme oxygenase in ischemic coronary vasodilation.
Nishikawa Y; Stepp DW; Merkus D; Jones D; Chilian WM
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2296-304. PubMed ID: 15148058
[TBL] [Abstract][Full Text] [Related]
9. Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF.
Wang X; Trottier G; Loutzenhiser R
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F540-9. PubMed ID: 12734100
[TBL] [Abstract][Full Text] [Related]
10. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform.
Beverelli F; Béa ML; Puybasset L; Giudicelli JF; Berdeaux A
Fundam Clin Pharmacol; 1997; 11(3):252-9. PubMed ID: 9243257
[TBL] [Abstract][Full Text] [Related]
11. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension.
Millette E; de Champlain J; Lamontagne D
J Hypertens; 2000 Dec; 18(12):1783-93. PubMed ID: 11132602
[TBL] [Abstract][Full Text] [Related]
12. Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle.
Schrage WG; Dietz NM; Eisenach JH; Joyner MJ
J Appl Physiol (1985); 2005 Apr; 98(4):1251-7. PubMed ID: 15563630
[TBL] [Abstract][Full Text] [Related]
13. Chronic nitric oxide synthase inhibition blunts endothelium-dependent function of conduit coronary arteries, not arterioles.
Ingram DG; Newcomer SC; Price EM; Eklund KE; McAllister RM; Laughlin MH
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2798-808. PubMed ID: 17259441
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.
Rahman AM; Murrow JR; Ozkor MA; Kavtaradze N; Lin J; De Staercke C; Hooper WC; Manatunga A; Hayek S; Quyyumi AA
J Vasc Res; 2014; 51(3):200-8. PubMed ID: 24925526
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor.
Bauersachs J; Popp R; Hecker M; Sauer E; Fleming I; Busse R
Circulation; 1996 Dec; 94(12):3341-7. PubMed ID: 8989149
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived hyperpolarizing factor, but not nitric oxide, is reversibly inhibited by brefeldin A.
Bauersachs J; Fleming I; Scholz D; Popp R; Busse R
Hypertension; 1997 Dec; 30(6):1598-605. PubMed ID: 9403589
[TBL] [Abstract][Full Text] [Related]
17. Enhanced release of endothelium-derived hyperpolarizing factor in small coronary arteries from rats with congestive heart failure.
Ueda A; Ohyanagi M; Koida S; Iwasaki T
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):615-21. PubMed ID: 16120187
[TBL] [Abstract][Full Text] [Related]
18. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo.
Yada T; Shimokawa H; Hiramatsu O; Shinozaki Y; Mori H; Goto M; Ogasawara Y; Kajiya F
J Am Coll Cardiol; 2007 Sep; 50(13):1272-8. PubMed ID: 17888845
[TBL] [Abstract][Full Text] [Related]
19. Effects of oxygen tension on flow-induced vasodilation in porcine coronary resistance arterioles.
Jimenez AH; Tanner MA; Caldwell WM; Myers PR
Microvasc Res; 1996 May; 51(3):365-77. PubMed ID: 8992234
[TBL] [Abstract][Full Text] [Related]
20. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery.
Kilpatrick EV; Cocks TM
Br J Pharmacol; 1994 Jun; 112(2):557-65. PubMed ID: 7521260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
